AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE

AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE was reported 50 times

AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PH BODY FLUID INCREASED 6 0.2609
1 GASTROINTESTINAL SUBMUCOSAL TUMOUR 6 0.1304
2 CARDIAC VALVE SCLEROSIS 6 0.0833
3 OPTIC NERVE NEOPLASM 4 0.0426
4 COSTOVERTEBRAL ANGLE TENDERNESS 6 0.0366
5 CEREBRAL MICROINFARCTION 2 0.0345
6 HYDROCHOLECYSTIS 6 0.0324
7 PERITONEAL ADHESIONS 6 0.0236
8 INFUSION SITE THROMBOSIS 6 0.0224
9 OXYGEN SATURATION INCREASED 6 0.0177
10 HYPOCALVARIA 2 0.0172
11 BLOOD INSULIN ABNORMAL 3 0.0160
12 BLADDER HYPERTROPHY 7 0.0158
13 CEREBRAL ARTERIOSCLEROSIS 6 0.0155
14 INFARCTION 100 0.0146
15 OCULAR MYASTHENIA 5 0.0146
16 CREATININE URINE INCREASED 4 0.0132
17 PO2 INCREASED 6 0.0118
18 LUMBAR HERNIA 2 0.0118
19 LEFT ATRIAL ENLARGEMENT 6 0.0111
20 BLOOD PRESSURE INADEQUATELY CONTROLLED 67 0.0111
21 BONE DECALCIFICATION 2 0.0109
22 HYPERTENSIVE CARDIOMYOPATHY 3 0.0108
23 BLOOD URIC ACID ABNORMAL 4 0.0098
24 SPINAL CORD DISORDER 15 0.0091
25 SENILE DEMENTIA 6 0.0090
26 PTERYGIUM 3 0.0087
27 ORTHOSTATIC INTOLERANCE 6 0.0084
28 CEREBRAL CALCIFICATION 2 0.0075
29 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0067
30 GINGIVAL HYPERPLASIA 4 0.0067
31 PCO2 DECREASED 6 0.0062
32 BREAST HAEMORRHAGE 2 0.0061
33 BOREDOM 2 0.0059
34 KERATOACANTHOMA 4 0.0058
35 PERFORATED ULCER 4 0.0053
36 PAROTITIS 6 0.0052
37 OPHTHALMOPLEGIA 8 0.0051
38 CHOROIDAL EFFUSION 4 0.0050
39 OXYGEN CONSUMPTION DECREASED 3 0.0050
40 HELICOBACTER GASTRITIS 6 0.0048
41 HYPERTENSIVE HEART DISEASE 9 0.0048
42 BONE FISSURE 2 0.0048
43 HYPERFERRITINAEMIA 2 0.0046
44 BLOOD CHROMOGRANIN A INCREASED 2 0.0044
45 CEREBRAL HYPOPERFUSION 2 0.0043
46 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
47 AORTIC VALVE SCLEROSIS 3 0.0041
48 HYPERCALCIURIA 2 0.0041
49 ADHESION 6 0.0040
50 HYPERTENSIVE CRISIS 44 0.0040
51 INTERVERTEBRAL DISC DISPLACEMENT 2 0.0038
52 DEAFNESS 99 0.0038
53 COATING IN MOUTH 2 0.0037
54 INTERLEUKIN LEVEL INCREASED 2 0.0036
55 JUGULAR VEIN DISTENSION 2 0.0035
56 ADENOMA BENIGN 3 0.0035
57 OPTIC NERVE INJURY 4 0.0034
58 NASAL CAVITY CANCER 3 0.0033
59 DIASTOLIC DYSFUNCTION 10 0.0032
60 BLOOD PRESSURE ABNORMAL 60 0.0030
61 BRAIN HYPOXIA 3 0.0030
62 DISTURBANCE IN SOCIAL BEHAVIOUR 7 0.0030
63 BLADDER DYSFUNCTION 3 0.0029
64 LEIOMYOMA 2 0.0029
65 ANGINA UNSTABLE 18 0.0028
66 APALLIC SYNDROME 2 0.0028
67 PRODUCT PRESCRIBING ERROR 65 0.0027
68 BENIGN NEOPLASM 3 0.0027
69 EMBOLISM 22 0.0026
70 BLOOD PRESSURE FLUCTUATION 63 0.0026
71 DISTRACTIBILITY 3 0.0026
72 CARDIOMEGALY 32 0.0026
73 BLOOD PRESSURE DECREASED 170 0.0026
74 BLOOD PRESSURE INCREASED 378 0.0025
75 DIABETES MELLITUS 188 0.0025
76 CARTILAGE INJURY 6 0.0024
77 CONCOMITANT DISEASE AGGRAVATED 15 0.0024
78 BLOOD URIC ACID INCREASED 14 0.0024
79 PALATAL OEDEMA 3 0.0024
80 OVERWEIGHT 13 0.0024
81 DYSPNOEA AT REST 7 0.0024
82 CAROTID ARTERY DISEASE 3 0.0024
83 MONOPLEGIA 10 0.0023
84 DUODENITIS 7 0.0023
85 BLOOD POTASSIUM ABNORMAL 6 0.0022
86 VENOUS OCCLUSION 4 0.0022
87 DENGUE FEVER 5 0.0022
88 ISCHAEMIA 10 0.0022
89 DIABETIC METABOLIC DECOMPENSATION 3 0.0022
90 DYSENTERY 4 0.0021
91 GASTRITIS EROSIVE 10 0.0021
92 FEELING OF DESPAIR 10 0.0021
93 VARICOSE VEIN 11 0.0021
94 BLOOD ELECTROLYTES DECREASED 3 0.0021
95 OSTEOPOROTIC FRACTURE 4 0.0021
96 ASPHYXIA 17 0.0021
97 MULTI-ORGAN DISORDER 4 0.0020
98 KNEE DEFORMITY 3 0.0020
99 CARDIAC ANEURYSM 2 0.0020
100 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
101 DIABETIC COMPLICATION 5 0.0020
102 VASCULAR RUPTURE 3 0.0019
103 METASTASES TO PLEURA 2 0.0019
104 SPINAL DISORDER 18 0.0019
105 BLOOD SODIUM ABNORMAL 2 0.0019
106 BLOOD SODIUM INCREASED 5 0.0019
107 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
108 OESOPHAGEAL DISORDER 7 0.0018
109 NEAR DEATH EXPERIENCE 6 0.0018
110 DIABETIC NEPHROPATHY 4 0.0018
111 TENSION 11 0.0018
112 VEIN RUPTURE 3 0.0018
113 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
114 LIGAMENT INJURY 2 0.0018
115 ACCIDENT 21 0.0018
116 BLOOD SODIUM DECREASED 33 0.0017
117 CEREBRAL ISCHAEMIA 9 0.0017
118 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
119 DILATATION ATRIAL 2 0.0017
120 VERTIGO POSITIONAL 3 0.0017
121 MYOPIA 4 0.0017
122 EMBOLISM ARTERIAL 2 0.0017
123 AORTIC VALVE INCOMPETENCE 7 0.0016
124 FACIAL PARALYSIS 14 0.0016
125 BLADDER PROLAPSE 2 0.0016
126 DIABETIC FOOT 5 0.0016
127 LARGE INTESTINE INFECTION 2 0.0016
128 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
129 RETINAL TEAR 4 0.0016
130 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
131 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
132 BILE DUCT STONE 5 0.0016
133 ARTERIAL DISORDER 3 0.0016
134 LEFT ATRIAL DILATATION 2 0.0016
135 ABDOMINAL INFECTION 4 0.0016
136 ARRHYTHMIA 74 0.0016
137 PHLEBITIS 8 0.0016
138 AORTIC ARTERIOSCLEROSIS 4 0.0016
139 ATROPHY 3 0.0015
140 LIBIDO DISORDER 2 0.0015
141 CONCOMITANT DISEASE PROGRESSION 3 0.0015
142 EAR DISORDER 7 0.0015
143 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
144 DRUG PRESCRIBING ERROR 29 0.0015
145 MUCOSAL DRYNESS 3 0.0015
146 BODY MASS INDEX INCREASED 2 0.0015
147 DIABETIC RETINOPATHY 5 0.0015
148 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
149 EFFUSION 2 0.0015
150 HYPERURICAEMIA 6 0.0015
151 POLYCYTHAEMIA 3 0.0015
152 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
153 DIABETIC NEUROPATHY 7 0.0014
154 ERYSIPELAS 7 0.0014
155 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
156 ENDOMETRIAL CANCER 3 0.0014
157 CARDIAC FIBRILLATION 2 0.0014
158 ACCIDENT AT WORK 3 0.0014
159 SPINAL COLUMN INJURY 3 0.0013
160 RENAL COLIC 3 0.0013
161 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
162 VARICES OESOPHAGEAL 4 0.0013
163 INTELLECTUAL DISABILITY 2 0.0013
164 HIATUS HERNIA 17 0.0013
165 GASTRIC INFECTION 5 0.0013
166 MASTICATION DISORDER 4 0.0013
167 MENOPAUSAL SYMPTOMS 3 0.0013
168 BLOOD CREATININE DECREASED 4 0.0013
169 VENOUS THROMBOSIS 5 0.0013
170 PROSTATIC DISORDER 7 0.0013
171 FAECES SOFT 9 0.0012
172 ARTHROPOD STING 2 0.0012
173 HEMIPLEGIA 10 0.0012
174 VEIN DISORDER 6 0.0012
175 NEPHRITIS 4 0.0012
176 RETINAL DETACHMENT 11 0.0012
177 EROSIVE OESOPHAGITIS 2 0.0012
178 LACTOSE INTOLERANCE 3 0.0012
179 ARTERIOSCLEROSIS 11 0.0012
180 PERIPHERAL VASCULAR DISORDER 6 0.0012
181 VIITH NERVE PARALYSIS 4 0.0012
182 HYPOPITUITARISM 2 0.0011
183 CHOLANGITIS 7 0.0011
184 BLINDNESS 46 0.0011
185 CATARACT 67 0.0011
186 EYE HAEMORRHAGE 15 0.0011
187 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 227 0.0011
188 APPARENT DEATH 4 0.0011
189 CHONDROPATHY 3 0.0011
190 CEREBRAL INFARCTION 27 0.0011
191 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
192 ESSENTIAL HYPERTENSION 2 0.0011
193 ASTHENOPIA 6 0.0011
194 HYPERTENSION 231 0.0011
195 DEAFNESS UNILATERAL 6 0.0011
196 RED BLOOD CELL COUNT INCREASED 3 0.0011
197 THYROID NEOPLASM 3 0.0011
198 BODY TEMPERATURE ABNORMAL 2 0.0011
199 METAMORPHOPSIA 2 0.0011
200 EATING DISORDER 23 0.0011
201 DIABETIC COMA 3 0.0011
202 KIDNEY INFECTION 21 0.0011
203 ADENOCARCINOMA OF COLON 2 0.0011
204 CEREBRAL THROMBOSIS 3 0.0011
205 SNORING 4 0.0011
206 THYROID MASS 4 0.0010
207 GINGIVAL RECESSION 2 0.0010
208 WRONG PRODUCT ADMINISTERED 7 0.0010
209 HYPOACUSIS 44 0.0010
210 STRABISMUS 3 0.0010
211 PROSTATOMEGALY 4 0.0010
212 ANGINA PECTORIS 29 0.0010
213 DIPLEGIA 2 0.0010
214 ATYPICAL PNEUMONIA 3 0.0010
215 FLUID RETENTION 51 0.0010
216 CEREBROVASCULAR DISORDER 3 0.0010
217 GANGRENE 6 0.0010
218 GLAUCOMA 19 0.0010
219 DIVERTICULAR PERFORATION 2 0.0010
220 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
221 FEAR 26 0.0010
222 GASTRITIS 25 0.0009
223 BREAST CANCER RECURRENT 3 0.0009
224 POOR PERIPHERAL CIRCULATION 4 0.0009
225 VISUAL IMPAIRMENT 114 0.0009
226 BIPOLAR I DISORDER 2 0.0009
227 LISTLESS 3 0.0009
228 THYROID DISORDER 14 0.0009
229 ANKLE FRACTURE 14 0.0009
230 CHOLESTATIC LIVER INJURY 2 0.0009
231 HYPOKINESIA 13 0.0009
232 ADENOCARCINOMA 2 0.0009
233 POLLAKIURIA 37 0.0009
234 RENAL CYST 7 0.0009
235 RENAL DISORDER 41 0.0009
236 HAEMATOCRIT INCREASED 2 0.0009
237 POISONING 11 0.0009
238 CARDIAC VALVE DISEASE 5 0.0009
239 DISEASE COMPLICATION 4 0.0009
240 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
241 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
242 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
243 RENAL FUNCTION TEST ABNORMAL 4 0.0009
244 HEPATIC STEATOSIS 16 0.0009
245 SPEECH DISORDER 45 0.0009
246 POLYURIA 7 0.0009
247 FACIAL PARESIS 3 0.0008
248 HAND FRACTURE 6 0.0008
249 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
250 COLORECTAL CANCER METASTATIC 2 0.0008
251 PLATELET COUNT INCREASED 11 0.0008
252 CHOLECYSTITIS 10 0.0008
253 GAIT INABILITY 28 0.0008
254 BLOOD CHOLESTEROL INCREASED 39 0.0008
255 LACUNAR INFARCTION 2 0.0008
256 POLYNEUROPATHY 10 0.0008
257 HEARING IMPAIRED 5 0.0008
258 HYPERCHOLESTEROLAEMIA 8 0.0008
259 LYMPHADENITIS 2 0.0008
260 FOOD INTOLERANCE 3 0.0008
261 PERIPHERAL SWELLING 126 0.0008
262 ABASIA 20 0.0008
263 GENERALISED OEDEMA 10 0.0008
264 BLOOD POTASSIUM DECREASED 24 0.0008
265 EMPHYSEMA 8 0.0008
266 HEAD DISCOMFORT 14 0.0008
267 FACE INJURY 3 0.0008
268 HAEMORRHAGE URINARY TRACT 2 0.0008
269 CANCER PAIN 2 0.0008
270 INCREASED BRONCHIAL SECRETION 2 0.0008
271 RENAL FAILURE CHRONIC 6 0.0008
272 PRODUCT COLOUR ISSUE 4 0.0008
273 BASAL CELL CARCINOMA 12 0.0008
274 PARALYSIS 11 0.0008
275 EPIGASTRIC DISCOMFORT 3 0.0008
276 EYE DISORDER 25 0.0008
277 OESOPHAGEAL PAIN 3 0.0008
278 POLYDIPSIA 3 0.0008
279 JOINT DISLOCATION 8 0.0008
280 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
281 CEREBRAL ATROPHY 3 0.0008
282 MUSCLE HAEMORRHAGE 3 0.0007
283 ALCOHOL POISONING 2 0.0007
284 TRIGEMINAL NEURALGIA 3 0.0007
285 LOCAL SWELLING 13 0.0007
286 BREAST MASS 5 0.0007
287 CEREBROVASCULAR ACCIDENT 126 0.0007
288 LIMB DISCOMFORT 23 0.0007
289 BLOOD PHOSPHORUS INCREASED 2 0.0007
290 CORONARY ARTERY OCCLUSION 10 0.0007
291 PHARYNGITIS 9 0.0007
292 CHOKING SENSATION 4 0.0007
293 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
294 CHOLECYSTITIS INFECTIVE 2 0.0007
295 CONGESTIVE CARDIOMYOPATHY 3 0.0007
296 BLOOD UREA INCREASED 12 0.0007
297 ANGIOPATHY 4 0.0007
298 THROAT CANCER 3 0.0007
299 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
300 CARDIAC FAILURE CHRONIC 3 0.0007
301 MYOCARDIAL ISCHAEMIA 8 0.0007
302 INTERVERTEBRAL DISC DISORDER 3 0.0007
303 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
304 OBESITY 11 0.0007
305 TONGUE DISCOLOURATION 3 0.0007
306 FOOT FRACTURE 13 0.0007
307 MOVEMENT DISORDER 22 0.0007
308 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
309 SLEEP APNOEA SYNDROME 13 0.0007
310 OEDEMA PERIPHERAL 83 0.0007
311 LIGAMENT RUPTURE 3 0.0007
312 ACUTE MYOCARDIAL INFARCTION 20 0.0007
313 METABOLIC ENCEPHALOPATHY 2 0.0007
314 URINARY TRACT DISORDER 3 0.0007
315 EYE INJURY 2 0.0007
316 HAEMOGLOBIN INCREASED 3 0.0007
317 INGUINAL HERNIA 4 0.0007
318 DYSCHEZIA 2 0.0007
319 BODY HEIGHT DECREASED 7 0.0007
320 CARDIAC DISORDER 61 0.0007
321 MENISCUS INJURY 4 0.0006
322 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
323 UMBILICAL HERNIA 3 0.0006
324 CHOLELITHIASIS 21 0.0006
325 TIBIA FRACTURE 3 0.0006
326 INFLAMMATION 33 0.0006
327 HEPATIC CIRRHOSIS 12 0.0006
328 HAEMATEMESIS 16 0.0006
329 ATRIAL FLUTTER 5 0.0006
330 INTRAOCULAR PRESSURE INCREASED 8 0.0006
331 ERECTILE DYSFUNCTION 16 0.0006
332 HERNIA 12 0.0006
333 RHINITIS 5 0.0006
334 FINGER DEFORMITY 3 0.0006
335 MEMORY IMPAIRMENT 85 0.0006
336 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
337 HEPATIC NEOPLASM 2 0.0006
338 MICTURITION URGENCY 7 0.0006
339 LYMPHOCYTE COUNT INCREASED 2 0.0006
340 SYNCOPE 61 0.0006
341 NEOPLASM 7 0.0006
342 OEDEMA 33 0.0006
343 EXPIRED DRUG ADMINISTERED 3 0.0006
344 ANEURYSM 3 0.0006
345 EYELID OEDEMA 7 0.0006
346 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
347 ANXIETY DISORDER 2 0.0006
348 SPINAL PAIN 7 0.0006
349 APHASIA 18 0.0006
350 BLOOD GLUCOSE ABNORMAL 11 0.0006
351 CEREBRAL HAEMATOMA 2 0.0006
352 HYPOTENSION 119 0.0006
353 METASTASES TO LYMPH NODES 4 0.0006
354 EYELID PTOSIS 6 0.0006
355 DRY THROAT 6 0.0006
356 HEMIPARESIS 10 0.0006
357 DRUG INTOLERANCE 57 0.0006
358 DISCOMFORT 36 0.0006
359 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
360 HEPATIC CYST 2 0.0006
361 HYPONATRAEMIA 33 0.0006
362 HYPOKALAEMIA 27 0.0006
363 BRONCHOPNEUMONIA 2 0.0006
364 PERIPHERAL COLDNESS 8 0.0006
365 RESPIRATION ABNORMAL 4 0.0006
366 BURSITIS 7 0.0006
367 FEELING ABNORMAL 138 0.0006
368 AORTIC STENOSIS 2 0.0006
369 EXTRASYSTOLES 4 0.0006
370 LOWER LIMB FRACTURE 11 0.0006
371 URINE OUTPUT DECREASED 5 0.0006
372 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
373 GAIT DISTURBANCE 109 0.0006
374 URINARY RETENTION 19 0.0006
375 MACULOPATHY 2 0.0006
376 GLOSSITIS 2 0.0006
377 PRODUCT SUPPLY ISSUE 4 0.0006
378 GASTROINTESTINAL INFECTION 5 0.0006
379 HAEMATOCRIT DECREASED 11 0.0006
380 BLOOD POTASSIUM INCREASED 9 0.0006
381 UPPER LIMB FRACTURE 11 0.0006
382 MONOCYTE COUNT INCREASED 2 0.0006
383 HYDROCEPHALUS 3 0.0006
384 RENAL FAILURE 73 0.0005
385 CAROTID ARTERY OCCLUSION 2 0.0005
386 DYSSTASIA 16 0.0005
387 UTERINE LEIOMYOMA 4 0.0005
388 ROTATOR CUFF SYNDROME 7 0.0005
389 BRAIN NEOPLASM 5 0.0005
390 NERVE INJURY 6 0.0005
391 FEELING DRUNK 4 0.0005
392 HEART RATE ABNORMAL 3 0.0005
393 CARDIAC DYSFUNCTION 2 0.0005
394 NERVOUSNESS 28 0.0005
395 HYPOTHYROIDISM 17 0.0005
396 CIRCULATORY COLLAPSE 9 0.0005
397 PRODUCT AVAILABILITY ISSUE 12 0.0005
398 BLOOD GLUCOSE INCREASED 99 0.0005
399 COMMUNICATION DISORDER 2 0.0005
400 ATRIOVENTRICULAR BLOCK 4 0.0005
401 PRESCRIBED OVERDOSE 10 0.0005
402 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
403 ELECTROLYTE IMBALANCE 6 0.0005
404 LIMB INJURY 14 0.0005
405 JOINT INJURY 11 0.0005
406 MUSCLE RUPTURE 2 0.0005
407 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
408 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
409 LIGAMENT SPRAIN 5 0.0005
410 PLEURISY 3 0.0005
411 ULCER 8 0.0005
412 TINNITUS 23 0.0005
413 SPINAL FRACTURE 10 0.0005
414 THYROID CANCER 6 0.0005
415 CARDIAC FAILURE 40 0.0005
416 INTRACRANIAL ANEURYSM 2 0.0005
417 LEUKOCYTOSIS 9 0.0005
418 BLINDNESS UNILATERAL 7 0.0005
419 CORONARY ARTERY DISEASE 15 0.0005
420 MUSCLE DISORDER 4 0.0005
421 PULMONARY OEDEMA 22 0.0005
422 CHROMATURIA 11 0.0005
423 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
424 PIGMENTATION DISORDER 3 0.0005
425 PARAESTHESIA ORAL 7 0.0005
426 MALAISE 210 0.0005
427 BLEPHAROSPASM 3 0.0005
428 SUDDEN DEATH 5 0.0005
429 LUNG DISORDER 23 0.0005
430 HEPATIC PAIN 2 0.0005
431 ABNORMAL SENSATION IN EYE 2 0.0005
432 MUSCULOSKELETAL DISCOMFORT 8 0.0005
433 SKIN CANCER 10 0.0005
434 METASTATIC NEOPLASM 2 0.0005
435 CARDIAC MURMUR 4 0.0005
436 PYELONEPHRITIS 4 0.0005
437 BIPOLAR DISORDER 5 0.0005
438 BONE CANCER 2 0.0005
439 PULMONARY THROMBOSIS 5 0.0005
440 POLYP 3 0.0005
441 BLOOD GLUCOSE FLUCTUATION 5 0.0005
442 MELANOCYTIC NAEVUS 2 0.0005
443 DYSPHEMIA 2 0.0005
444 DYSGRAPHIA 3 0.0005
445 HAEMORRHAGIC ANAEMIA 2 0.0005
446 CORONAVIRUS INFECTION 3 0.0005
447 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
448 TERMINAL STATE 3 0.0004
449 ILLNESS 46 0.0004
450 OCULAR DISCOMFORT 5 0.0004
451 IRON DEFICIENCY 2 0.0004
452 OROPHARYNGEAL DISCOMFORT 4 0.0004
453 COVID-19 77 0.0004
454 ABDOMINAL HERNIA 2 0.0004
455 RESPIRATORY ARREST 12 0.0004
456 GASTRIC HAEMORRHAGE 5 0.0004
457 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
458 LOCALISED OEDEMA 2 0.0004
459 HYPOMAGNESAEMIA 6 0.0004
460 APPENDICITIS 4 0.0004
461 SWELLING 40 0.0004
462 HEART RATE DECREASED 15 0.0004
463 DUODENAL ULCER 3 0.0004
464 OSTEOARTHRITIS 18 0.0004
465 DIVERTICULUM 3 0.0004
466 EMOTIONAL DISORDER 13 0.0004
467 METASTASIS 3 0.0004
468 DEPRESSED MOOD 22 0.0004
469 APHAGIA 2 0.0004
470 EPISTAXIS 31 0.0004
471 GUILLAIN-BARRE SYNDROME 2 0.0004
472 DIZZINESS POSTURAL 4 0.0004
473 VERTIGO 25 0.0004
474 HORMONE LEVEL ABNORMAL 2 0.0004
475 INCORRECT DOSAGE ADMINISTERED 2 0.0004
476 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
477 BLINDNESS TRANSIENT 3 0.0004
478 CEREBRAL DISORDER 3 0.0004
479 BLADDER DISORDER 4 0.0004
480 PULMONARY MASS 6 0.0004
481 FALL 134 0.0004
482 SALIVARY HYPERSECRETION 4 0.0004
483 DERMATITIS EXFOLIATIVE 2 0.0004
484 CORONARY ARTERY STENOSIS 2 0.0004
485 PEMPHIGOID 3 0.0004
486 MYOCARDIAL INFARCTION 69 0.0004
487 OSTEOPENIA 6 0.0004
488 MOTOR DYSFUNCTION 4 0.0004
489 BOWEL MOVEMENT IRREGULARITY 3 0.0004
490 NEOPLASM MALIGNANT 26 0.0004
491 OSTEOPOROSIS 16 0.0004
492 BURNING SENSATION 27 0.0004
493 EYE DISCHARGE 4 0.0004
494 MALABSORPTION 2 0.0004
495 TACHYCARDIA 34 0.0004
496 PULMONARY CONGESTION 5 0.0004
497 RENAL PAIN 4 0.0004
498 ANORECTAL DISCOMFORT 2 0.0004
499 BONE PAIN 22 0.0004
500 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
501 THROMBOSIS 30 0.0004
502 SENSORY LOSS 3 0.0004
503 POOR QUALITY SLEEP 8 0.0004
504 URINARY INCONTINENCE 11 0.0004
505 POST PROCEDURAL INFECTION 3 0.0004
506 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66 0.0004
507 ACUTE HEPATIC FAILURE 5 0.0004
508 WEIGHT DECREASED 102 0.0004
509 BREAST CANCER 34 0.0004
510 CHOLESTASIS 7 0.0004
511 VISION BLURRED 50 0.0004
512 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
513 ACUTE CORONARY SYNDROME 3 0.0004
514 INTRACRANIAL PRESSURE INCREASED 2 0.0004
515 CHOKING 7 0.0004
516 INFLUENZA 40 0.0004
517 APHONIA 5 0.0004
518 MACULAR OEDEMA 2 0.0004
519 TYPE 2 DIABETES MELLITUS 12 0.0004
520 JOINT SWELLING 43 0.0004
521 PRODUCTIVE COUGH 17 0.0004
522 FEMUR FRACTURE 11 0.0004
523 CARDIOVASCULAR DISORDER 9 0.0004
524 DYSURIA 13 0.0004
525 BLOOD CREATININE INCREASED 23 0.0004
526 DIZZINESS 175 0.0004
527 RASH GENERALISED 9 0.0003
528 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
529 MUSCLE STRAIN 3 0.0003
530 DIPLOPIA 9 0.0003
531 METASTASES TO LUNG 4 0.0003
532 METABOLIC DISORDER 2 0.0003
533 MUSCULOSKELETAL PAIN 18 0.0003
534 NAIL DISORDER 3 0.0003
535 HYPERKALAEMIA 12 0.0003
536 HIP FRACTURE 11 0.0003
537 PALPITATIONS 40 0.0003
538 RIB FRACTURE 7 0.0003
539 ISCHAEMIC STROKE 6 0.0003
540 COLON CANCER 5 0.0003
541 MACULAR DEGENERATION 4 0.0003
542 ROAD TRAFFIC ACCIDENT 14 0.0003
543 WRIST FRACTURE 4 0.0003
544 ILL-DEFINED DISORDER 20 0.0003
545 END STAGE RENAL DISEASE 6 0.0003
546 SKIN LESION 9 0.0003
547 LOSS OF CONSCIOUSNESS 42 0.0003
548 DRUG DISPENSING ERROR 5 0.0003
549 EPILEPSY 10 0.0003
550 NEPHROLITHIASIS 15 0.0003
551 ANGER 11 0.0003
552 UROSEPSIS 3 0.0003
553 TENDON RUPTURE 4 0.0003
554 CHEST PAIN 60 0.0003
555 PAIN IN EXTREMITY 95 0.0003
556 WOUND 9 0.0003
557 MENTAL DISORDER 14 0.0003
558 RENAL IMPAIRMENT 27 0.0003
559 EXTRA DOSE ADMINISTERED 13 0.0003
560 BRADYCARDIA 17 0.0003
561 MOBILITY DECREASED 23 0.0003
562 FLANK PAIN 3 0.0003
563 SQUAMOUS CELL CARCINOMA 3 0.0003
564 DYSPNOEA EXERTIONAL 12 0.0003
565 BRAIN OEDEMA 4 0.0003
566 HEAD INJURY 10 0.0003
567 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
568 GASTRIC ULCER 6 0.0003
569 HALLUCINATION, AUDITORY 5 0.0003
570 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
571 CYSTITIS 10 0.0003
572 SCIATICA 5 0.0003
573 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
574 POST PROCEDURAL COMPLICATION 6 0.0003
575 INCORRECT DOSE ADMINISTERED 71 0.0003
576 ERUCTATION 6 0.0003
577 CARDIAC FLUTTER 2 0.0003
578 INCOHERENT 2 0.0003
579 HAEMATOMA 8 0.0003
580 VITAMIN D DEFICIENCY 3 0.0003
581 COELIAC DISEASE 3 0.0003
582 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
583 RENAL INJURY 9 0.0003
584 DISORIENTATION 12 0.0003
585 C-REACTIVE PROTEIN INCREASED 11 0.0003
586 PRESCRIBED UNDERDOSE 6 0.0003
587 HYPOTONIA 3 0.0003
588 LIP SWELLING 10 0.0003
589 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
590 DEATH 256 0.0003
591 BRONCHIECTASIS 2 0.0003
592 FACE OEDEMA 5 0.0003
593 EYE SWELLING 11 0.0003
594 PALLOR 8 0.0003
595 GINGIVAL BLEEDING 4 0.0003
596 INITIAL INSOMNIA 3 0.0003
597 EAR DISCOMFORT 3 0.0003
598 HAEMOGLOBIN DECREASED 30 0.0003
599 LUNG NEOPLASM MALIGNANT 12 0.0003
600 SWELLING FACE 19 0.0003
601 CARDIAC ARREST 24 0.0003
602 LYMPHOEDEMA 2 0.0003
603 MENTAL IMPAIRMENT 7 0.0003
604 DIVERTICULITIS 8 0.0003
605 NERVOUS SYSTEM DISORDER 9 0.0003
606 FIBROMYALGIA 7 0.0003
607 PRESYNCOPE 7 0.0003
608 HYPERTRANSAMINASAEMIA 2 0.0003
609 FEELING COLD 8 0.0003
610 WEIGHT FLUCTUATION 3 0.0003
611 DEMENTIA 8 0.0003
612 MASS 4 0.0003
613 ANXIETY 81 0.0003
614 METASTASES TO LIVER 5 0.0003
615 EYE PAIN 16 0.0003
616 AGEUSIA 7 0.0003
617 THIRST 5 0.0003
618 CEREBRAL HAEMORRHAGE 10 0.0003
619 GOUT 5 0.0003
620 FEELING HOT 17 0.0003
621 ABDOMINAL PAIN LOWER 7 0.0003
622 ANOSMIA 4 0.0003
623 TOOTHACHE 5 0.0003
624 HEADACHE 173 0.0003
625 SKIN LACERATION 3 0.0003
626 BONE DISORDER 5 0.0003
627 IMPAIRED HEALING 9 0.0003
628 MELAENA 6 0.0003
629 FOOT DEFORMITY 3 0.0003
630 HYPOPHOSPHATAEMIA 2 0.0003
631 ARTHROPATHY 15 0.0003
632 SLEEP DISORDER 19 0.0003
633 NECK PAIN 15 0.0003
634 IMMUNODEFICIENCY 4 0.0003
635 DEPRESSION 61 0.0003
636 BACTERIAL INFECTION 5 0.0003
637 NEPHROPATHY TOXIC 3 0.0003
638 PANCREATITIS ACUTE 6 0.0003
639 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
640 BONE LOSS 4 0.0003
641 HYPOAESTHESIA ORAL 4 0.0003
642 COLITIS 10 0.0003
643 CARDIO-RESPIRATORY ARREST 11 0.0003
644 CHOLECYSTECTOMY 3 0.0003
645 INTERNAL HAEMORRHAGE 3 0.0003
646 DEHYDRATION 35 0.0003
647 SHOCK 6 0.0003
648 PULMONARY FIBROSIS 5 0.0003
649 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
650 DRY EYE 13 0.0003
651 JAUNDICE 7 0.0003
652 FOOD ALLERGY 2 0.0003
653 DRY MOUTH 21 0.0003
654 LYMPHOMA 4 0.0003
655 ABDOMINAL PAIN UPPER 53 0.0003
656 EAR PAIN 5 0.0003
657 SWOLLEN TONGUE 8 0.0003
658 HAEMORRHAGIC STROKE 2 0.0003
659 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
660 AFFECTIVE DISORDER 2 0.0003
661 OCULAR HYPERAEMIA 12 0.0003
662 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
663 PNEUMOTHORAX 4 0.0003
664 GINGIVAL PAIN 2 0.0003
665 HYPERLIPIDAEMIA 3 0.0003
666 MUSCLE RIGIDITY 3 0.0003
667 CHRONIC KIDNEY DISEASE 19 0.0002
668 DIABETIC KETOACIDOSIS 6 0.0002
669 BLOOD DISORDER 2 0.0002
670 NIGHT SWEATS 8 0.0002
671 FRUSTRATION TOLERANCE DECREASED 2 0.0002
672 NOCTURIA 3 0.0002
673 PLEURAL EFFUSION 15 0.0002
674 ANAEMIA 47 0.0002
675 BACK DISORDER 4 0.0002
676 BACK PAIN 57 0.0002
677 THROAT IRRITATION 11 0.0002
678 AGITATION 18 0.0002
679 ABNORMAL FAECES 2 0.0002
680 METASTASES TO BONE 4 0.0002
681 COUGH 68 0.0002
682 PHOTOSENSITIVITY REACTION 4 0.0002
683 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
684 CYST 3 0.0002
685 TOOTH EXTRACTION 3 0.0002
686 HYPOAESTHESIA 36 0.0002
687 SKIN DISCOLOURATION 11 0.0002
688 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
689 HAEMODIALYSIS 2 0.0002
690 PNEUMONIA 77 0.0002
691 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
692 RENAL FAILURE ACUTE 10 0.0002
693 ARTHRALGIA 97 0.0002
694 WEIGHT INCREASED 52 0.0002
695 LACRIMATION INCREASED 7 0.0002
696 OXYGEN SATURATION DECREASED 13 0.0002
697 PRURITUS GENERALISED 5 0.0002
698 PRODUCT DISPENSING ERROR 5 0.0002
699 BLOOD GLUCOSE DECREASED 11 0.0002
700 ASTHENIA 86 0.0002
701 URINARY TRACT INFECTION 39 0.0002
702 CONTUSION 22 0.0002
703 BLOOD CALCIUM INCREASED 2 0.0002
704 ANKYLOSING SPONDYLITIS 3 0.0002
705 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
706 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
707 RASH MACULO-PAPULAR 5 0.0002
708 GALLBLADDER DISORDER 4 0.0002
709 FACIAL PAIN 2 0.0002
710 ORAL PAIN 5 0.0002
711 DISTURBANCE IN ATTENTION 12 0.0002
712 ANAL INCONTINENCE 2 0.0002
713 HEART RATE IRREGULAR 5 0.0002
714 MOOD ALTERED 6 0.0002
715 EXOSTOSIS 2 0.0002
716 OFF LABEL USE 191 0.0002
717 IRON DEFICIENCY ANAEMIA 2 0.0002
718 AMNESIA 14 0.0002
719 SUICIDE ATTEMPT 13 0.0002
720 CARPAL TUNNEL SYNDROME 3 0.0002
721 INSOMNIA 57 0.0002
722 HEART RATE INCREASED 21 0.0002
723 LEUKAEMIA 2 0.0002
724 MYALGIA 36 0.0002
725 HEPATOCELLULAR INJURY 3 0.0002
726 FRACTURE 4 0.0002
727 VISUAL ACUITY REDUCED 7 0.0002
728 VIRAL INFECTION 7 0.0002
729 COMA 10 0.0002
730 CARDIOGENIC SHOCK 3 0.0002
731 PANCREATITIS 11 0.0002
732 HEPATIC CANCER 5 0.0002
733 ACUTE RESPIRATORY FAILURE 4 0.0002
734 MUSCLE SPASMS 38 0.0002
735 HYPOGLYCAEMIA 10 0.0002
736 APATHY 3 0.0002
737 ATRIAL FIBRILLATION 20 0.0002
738 CHEST DISCOMFORT 21 0.0002
739 CHILLS 24 0.0002
740 HAEMATURIA 7 0.0002
741 HEPATOMEGALY 2 0.0002
742 KNEE OPERATION 2 0.0002
743 CARDIOMYOPATHY 3 0.0002
744 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
745 SKIN HAEMORRHAGE 3 0.0002
746 DRUG INTERACTION 32 0.0002
747 RASH MACULAR 7 0.0002
748 SOMNOLENCE 40 0.0002
749 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
750 DECREASED APPETITE 46 0.0002
751 PARAESTHESIA 31 0.0002
752 BALANCE DISORDER 17 0.0002
753 BODY TEMPERATURE INCREASED 4 0.0002
754 DEVICE RELATED INFECTION 3 0.0002
755 PERITONITIS 4 0.0002
756 DYSPNOEA 109 0.0002
757 HYPERGLYCAEMIA 7 0.0002
758 PULMONARY HYPERTENSION 4 0.0002
759 JOINT STIFFNESS 5 0.0002
760 PAIN 117 0.0002
761 PRODUCT USE COMPLAINT 3 0.0002
762 DYSPHAGIA 18 0.0002
763 INCONTINENCE 2 0.0002
764 HYPERSENSITIVITY 35 0.0002
765 ABSCESS 3 0.0002
766 FATIGUE 146 0.0002
767 IRRITABLE BOWEL SYNDROME 4 0.0002
768 PROSTATE CANCER 15 0.0002
769 LIVER FUNCTION TEST INCREASED 4 0.0002
770 ERYTHEMA 38 0.0002
771 THROAT TIGHTNESS 5 0.0002
772 ABDOMINAL DISCOMFORT 31 0.0002
773 OROPHARYNGEAL PAIN 17 0.0002
774 PNEUMONITIS 5 0.0002
775 ACUTE KIDNEY INJURY 28 0.0002
776 MULTIPLE FRACTURES 3 0.0002
777 GASTROINTESTINAL PAIN 2 0.0002
778 ANGIOEDEMA 8 0.0002
779 COAGULOPATHY 3 0.0002
780 THROMBOCYTOPENIA 20 0.0002
781 HYPERHIDROSIS 23 0.0002
782 RESPIRATORY FAILURE 13 0.0002
783 INTESTINAL PERFORATION 2 0.0002
784 FLATULENCE 10 0.0002
785 DERMATITIS CONTACT 2 0.0002
786 MULTI-ORGAN FAILURE 3 0.0002
787 PANCREATIC CARCINOMA 5 0.0002
788 DYSPEPSIA 17 0.0002
789 LIVER FUNCTION TEST ABNORMAL 5 0.0002
790 INTENTIONAL OVERDOSE 11 0.0002
791 ASCITES 5 0.0002
792 BLOOD IRON DECREASED 2 0.0002
793 ATAXIA 2 0.0002
794 NEUROPATHY PERIPHERAL 16 0.0002
795 GASTROINTESTINAL DISORDER 15 0.0002
796 MUSCULAR WEAKNESS 19 0.0002
797 RESPIRATORY DISORDER 5 0.0002
798 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
799 HEPATIC FAILURE 5 0.0002
800 HEPATITIS C 2 0.0002
801 LOCALISED INFECTION 4 0.0002
802 PANIC ATTACK 6 0.0002
803 NEURALGIA 4 0.0002
804 BRONCHITIS 12 0.0002
805 AGRANULOCYTOSIS 3 0.0002
806 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
807 SEPTIC SHOCK 7 0.0002
808 PNEUMONIA ASPIRATION 4 0.0002
809 INJECTION SITE DISCOLOURATION 2 0.0002
810 DERMATITIS ALLERGIC 2 0.0002
811 MUSCLE ATROPHY 2 0.0002
812 HYPOPHAGIA 4 0.0002
813 DRUG RESISTANCE 4 0.0002
814 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
815 LACTIC ACIDOSIS 5 0.0002
816 HAEMORRHOIDS 3 0.0002
817 SKIN FISSURES 3 0.0002
818 ARTHRITIS 12 0.0002
819 NASOPHARYNGITIS 28 0.0002
820 DIARRHOEA 98 0.0002
821 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
822 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
823 EXPIRED PRODUCT ADMINISTERED 5 0.0002
824 IRRITABILITY 9 0.0001
825 PRODUCT ADMINISTRATION ERROR 3 0.0001
826 FEEDING DISORDER 3 0.0001
827 PULMONARY EMBOLISM 14 0.0001
828 RENAL CANCER 7 0.0001
829 HAEMORRHAGE 15 0.0001
830 VOMITING 67 0.0001
831 INJURY 10 0.0001
832 HALLUCINATION, VISUAL 3 0.0001
833 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
834 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
835 BRONCHOSPASM 2 0.0001
836 LEUKOPENIA 7 0.0001
837 RED BLOOD CELL COUNT DECREASED 4 0.0001
838 LETHARGY 8 0.0001
839 FAECES DISCOLOURED 3 0.0001
840 INJECTION SITE HAEMATOMA 2 0.0001
841 PRODUCT PRESCRIBING ISSUE 3 0.0001
842 CRYING 5 0.0001
843 FLUID OVERLOAD 2 0.0001
844 INTENTIONAL PRODUCT MISUSE 12 0.0001
845 RESTLESSNESS 5 0.0001
846 GLOSSODYNIA 3 0.0001
847 HAEMORRHAGE INTRACRANIAL 2 0.0001
848 DYSARTHRIA 5 0.0001
849 INTESTINAL OBSTRUCTION 5 0.0001
850 TREMOR 22 0.0001
851 DRUG INEFFECTIVE 174 0.0001
852 ECONOMIC PROBLEM 2 0.0001
853 DRUG DEPENDENCE 21 0.0001
854 PYREXIA 45 0.0001
855 DRUG EFFECT DECREASED 7 0.0001
856 CONFUSIONAL STATE 21 0.0001
857 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
858 PERICARDIAL EFFUSION 3 0.0001
859 LUNG INFECTION 2 0.0001
860 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
861 HAEMATOCHEZIA 7 0.0001
862 BLISTER 7 0.0001
863 INFECTION 18 0.0001
864 ASTHMA 14 0.0001
865 RHEUMATOID ARTHRITIS 14 0.0001
866 DYSKINESIA 5 0.0001
867 CONVULSION 7 0.0001
868 HERPES ZOSTER 7 0.0001
869 SKIN DISORDER 4 0.0001
870 HALLUCINATION 9 0.0001
871 SURGERY 7 0.0001
872 NASAL CONGESTION 7 0.0001
873 EYE PRURITUS 4 0.0001
874 CONDITION AGGRAVATED 36 0.0001
875 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
876 GASTRIC DISORDER 4 0.0001
877 NAUSEA 92 0.0001
878 ABDOMINAL PAIN 27 0.0001
879 SKIN ULCER 3 0.0001
880 OVERDOSE 25 0.0001
881 DELIRIUM 4 0.0001
882 VAGINAL HAEMORRHAGE 5 0.0001
883 RESPIRATORY TRACT INFECTION 3 0.0001
884 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
885 COLD SWEAT 2 0.0001
886 PRURITUS 43 0.0001
887 PAIN OF SKIN 3 0.0001
888 GASTROENTERITIS VIRAL 2 0.0001
889 ANAPHYLACTIC REACTION 6 0.0001
890 FLUSHING 11 0.0001
891 DEEP VEIN THROMBOSIS 7 0.0001
892 PRODUCT USE ISSUE 20 0.0001
893 HYPOCALCAEMIA 2 0.0001
894 ABDOMINAL DISTENSION 11 0.0001
895 HYPERSOMNIA 3 0.0001
896 MULTIPLE SCLEROSIS 5 0.0001
897 EYE IRRITATION 6 0.0001
898 DYSPHONIA 6 0.0001
899 SEPSIS 11 0.0001
900 SINUSITIS 10 0.0001
901 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
902 MOUTH ULCERATION 2 0.0001
903 MIGRAINE 9 0.0001
904 DYSGEUSIA 7 0.0001
905 METABOLIC ACIDOSIS 3 0.0001
906 HOT FLUSH 7 0.0001
907 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
908 ALOPECIA 18 0.0001
909 LIVER DISORDER 4 0.0001
910 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
911 NEOPLASM PROGRESSION 3 0.0001
912 HYPOXIA 3 0.0001
913 WHEEZING 5 0.0001
914 PSORIASIS 11 0.0001
915 DISEASE RECURRENCE 4 0.0001
916 COLORECTAL CANCER 4 0.0001
917 URTICARIA 14 0.0001
918 DRY SKIN 11 0.0001
919 LIVER INJURY 2 0.0001
920 INJECTION SITE MASS 3 0.0001
921 AGGRESSION 4 0.0001
922 MUSCULOSKELETAL STIFFNESS 7 0.0001
923 CELLULITIS 4 0.0001
924 ACNE 6 0.0001
925 HEPATITIS 2 0.0001
926 CONSTIPATION 17 0.0001
927 SEIZURE 9 0.0001
928 EAR INFECTION 2 0.0001
929 PSORIATIC ARTHROPATHY 3 0.0001
930 TREATMENT NONCOMPLIANCE 4 0.0001
931 INFLUENZA LIKE ILLNESS 6 0.0001
932 ABNORMAL DREAMS 2 0.0001
933 MENTAL STATUS CHANGES 2 0.0001
934 RHABDOMYOLYSIS 3 0.0001
935 HAEMOPTYSIS 2 0.0001
936 SKIN EXFOLIATION 6 0.0001
937 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
938 INTENTIONAL DOSE OMISSION 2 0.0001
939 RECTAL HAEMORRHAGE 3 0.0001
940 BLADDER CANCER 4 0.0001
941 COLITIS ULCERATIVE 3 0.0001
942 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
943 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
944 PLATELET COUNT DECREASED 7 0.0001
945 DRUG ADMINISTRATION ERROR 2 0.0001
946 BONE DENSITY DECREASED 2 0.0001
947 RASH ERYTHEMATOUS 3 0.0001
948 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
949 NO ADVERSE EVENT 11 0.0001
950 FEBRILE NEUTROPENIA 4 0.0001
951 TOXICITY TO VARIOUS AGENTS 10 0.0001
952 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
953 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
954 LYMPHADENOPATHY 2 0.0001
955 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
956 RASH 24 0.0001
957 ACCIDENTAL OVERDOSE 2 0.0001
958 UNEVALUABLE EVENT 4 0.0001
959 PRODUCT SUBSTITUTION ISSUE 3 0.0001
960 ABNORMAL BEHAVIOUR 2 0.0001
961 THERAPEUTIC RESPONSE DECREASED 3 0.0000
962 TREATMENT FAILURE 4 0.0000
963 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
964 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
965 SUICIDAL IDEATION 4 0.0000
966 COGNITIVE DISORDER 2 0.0000
967 DISEASE PROGRESSION 5 0.0000
968 SKIN BURNING SENSATION 3 0.0000
969 INTERSTITIAL LUNG DISEASE 2 0.0000
970 EMOTIONAL DISTRESS 5 0.0000
971 INJECTION SITE HAEMORRHAGE 3 0.0000
972 PRODUCT DOSE OMISSION ISSUE 11 0.0000
973 CARDIAC FAILURE CONGESTIVE 3 0.0000
974 MEDICATION ERROR 2 0.0000
975 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
976 EXPOSURE DURING PREGNANCY 2 0.0000
977 DRUG DOSE OMISSION 5 0.0000
978 INJECTION SITE PRURITUS 2 0.0000
979 NEUTROPENIA 4 0.0000
980 HEPATIC ENZYME INCREASED 2 0.0000
981 DEVICE MALFUNCTION 2 0.0000
982 INJECTION SITE SWELLING 2 0.0000
983 INJECTION SITE PAIN 8 0.0000
984 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
985 DRUG WITHDRAWAL SYNDROME 2 0.0000
986 PRODUCT QUALITY ISSUE 3 0.0000
987 ADVERSE EVENT 2 0.0000
988 HOSPITALISATION 3 0.0000